MDIHX
Price
$29.88
Change
+$0.19 (+0.64%)
Updated
Jun 2 closing price
Net Assets
44.56B
MICIX
Price
$11.69
Change
+$0.10 (+0.86%)
Updated
Jun 2 closing price
Net Assets
335.11M
Interact to see
Advertisement

MDIHX vs MICIX

Header iconMDIHX vs MICIX Comparison
Open Charts MDIHX vs MICIXBanner chart's image
MDIHX vs MICIX Comparison Chart in %
View a ticker or compare two or three
VS
MDIHX vs. MICIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDIHX is a Hold and MICIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 44.6B vs. MICIX (335M). MICIX pays higher dividends than MDIHX: MICIX (2.52) vs MDIHX (1.85). MDIHX was incepted earlier than MICIX: MDIHX (21 years) vs MICIX (19 years). MICIX (1.43) is less costly to investors than MDIHX (1.10). MICIX is a more actively managed with annual turnover of: 44.00 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than MICIX: MDIHX (0) vs MICIX (2000000). MICIX annual gain was more profitable for investors over the last year : 28.50 vs. MDIHX (17.73). MICIX return over 5 years is better than : 60.13 vs. MDIHX (27.94).
MDIHXMICIXMDIHX / MICIX
Total Expense Ratio1.080.60180%
Annual Report Gross Expense Ratio1.101.4377%
Fund Existence21 years19 years-
Gain YTD9.43617.78553%
Front LoadN/AN/A-
Min. Initial Investment02000000-
Min. Initial Investment IRAN/AN/A-
Net Assets44.6B335M13,313%
Annual Yield % from dividends1.852.5274%
Returns for 1 year17.7328.5062%
Returns for 3 years46.9979.1359%
Returns for 5 years27.9460.1346%
Returns for 10 years123.06132.7293%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPMA25.100.03
+0.12%
Sound Point Meridian Capital Inc
LEVI22.86-0.32
-1.38%
Levi Strauss & Co
ATYR0.52-0.03
-4.87%
aTyr Pharma Inc
FBRX18.17-1.06
-5.54%
Forte Biosciences Inc
NRIX16.36-1.03
-5.92%
Nurix Therapeutics